Health
Drug before sex halves risk of HIV infection - experts
Publish Date: Jun 15, 2013
Drug before sex halves risk of HIV infection - experts
  • mail
  • img
newvision

By Hilary Bainemigisha

Results of a trial in Bangkok, Thailand have revealed that using Tenofovir, an ARV, daily, can reduce the risk of acquiring HIV by almost 50%.

The findings were released this week as the first evidence that daily medication of the drug, which is already part of the combinations used to treat HIV, can reduce the risk of acquiring HIV. The results of the study, which were done since 2005 among 2,413 people who use injectable drugs in Bangkok city-run drug treatment clinics, are published online in the Lancet.

Using a known medicine for an infection you do not have but fear to get is known as pre-exposure prophylaxis (PrEP). Scientists have been studying how people who are at high risk, especially those who have HIV positive partners (discordant couples), can be protected from infection using PrEP.

Some of those studies have already proven effective in reducing sexual transmission of HIV. This study is new revelation that even people who are likely to get HIV from sharing needles, can be protected by PrEP.

Dr. Patrick Ndase, the regional HIV prevention research expert, said this just confirms what scientists now believe is the potential of the drugs Tenofovir and Truvada.

‘‘What remains now is to decide how best to implement PrEP in conjunction with other proven prevention measures against HIV,’’ he says.

“Right now, we are struggling with the Ministry of Health to be more proactive for discordant couples and at least issue guidelines on how to use PrEP.”

“People are already using these drugs whenever they suspect that their partners are HIV positive. Misguided use will cause avoidable problems,” Ndase said.

He said to use PrEP, one must first confirm that they are HIV negative and not rely on tests that were made some time ago. Taking it when one is already HIV positive is dangerous because it gives the virus an underdose, leading to resistance issues.
“PrEP should be taken daily one week before and after unprotected sex with a person who is HIV positive. It helps discordant couples who have been on condoms but are planning to have a baby.”

According to the Lancet, the Bangkok study tested a daily oral pill of Tenofovir and concluded that the risk of HIV had been reduced by 49%. There were 17 HIV infections among the volunteers who were taking Tenofovir, compared to 33 infections among those on the placebo. This translates into a statistically significant 49% reduction in risk of HIV acquisition overall. However, participants who took the medication consistently saw a 74% reduction in HIV transmission, underscoring the importance of adherence. There were no significant safety concerns and no one who became infected with HIV during the trial developed drug resistance.

 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Condoms
Ugandan MPs have been inundated with complaints that many condoms on sale are too small, warning the problem is a blow to the fight against AIDS....
New super-thin, skin-like condom being developed
The billionaire philanthropist says progress is being made on developing a "next-generation" ultra-thin, skin-like condom that could offer better sexual pleasure,...
Students push for Tobacco Control Bill passing
Students from five universities are petitioning parliament to pass the tobacco control bill, arguing that it has stayed too long on the shelf....
Mulago Hospital improves patients’ diet
Uganda’s national referral health facility Mulago Hospital has made adjustments to the meals it serves its in-patients, with a special diet introduced....
Obama: Ebola crisis
President Barack Obama issues a global call to action to fight the Ebola epidemic, warning the deadly outbreak was "spiraling out of control"....
200 Ugandan patients for sickle cell drug trial
At least 200 patients are to take part in a clinical trial for a more effective drug used to treat sickle cell anaemia....
Do you think installing CCTV cameras in public places will help in the fight against terrorism?
Yes
No
Can't Say
follow us
subscribe to our news letter